Below are the most recent publications written about "Cross Reactions" by people in Profiles.
-
Voigt TB, Ghosh N, Rosen BC, Newbolt T, Louw JJ, Yrizarry-Medina A, Panayiotou C, Mauter JT, de Figueiredo Godoy G, Terao J, Rakasz EG, Reynolds MR, Dudley DM, Watkins DI, Ricciardi MJ. Heterologous Sequential mRNA Vaccination of Indian Rhesus Macaques Elicits Broad Binding and Neutralizing Antibody Responses Against Diverse Henipaviruses. Viruses. 2026 Apr 23; 18(5).
-
Iacone Y, Zikos J, Foehl D, Katyal P, Gollamudi V, Bibb L, Magnani DM. Development of anti-IgA monoclonal and polyclonal reagents for detecting mucosal and systemic IgA in nonhuman primates. J Immunol Methods. 2026 May; 548:114054.
-
Ganta KK, McManus M, Blanc R, Wang Q, Jung W, Brody R, Carrington M, Paris R, Chandramouli S, McNamara RP, Luzuriaga K. Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta. Cell Rep. 2025 May 27; 44(5):115709.
-
Spencer DM, Svenungsson E, Gunnarsson I, Caricchio R, Pisetsky DS. The expression of antibodies to Z-DNA in the blood of patients with systemic lupus erythematosus: Relationship to autoantibodies to B-DNA. Clin Immunol. 2023 10; 255:109763.
-
Katzelnick LC, Zambrana JV, Elizondo D, Collado D, Garcia N, Arguello S, Mercado JC, Miranda T, Ampie O, Mercado BL, Narvaez C, Gresh L, Binder RA, Ojeda S, Sanchez N, Plazaola M, Latta K, Schiller A, Coloma J, Carrillo FB, Narvaez F, Halloran ME, Gordon A, Kuan G, Balmaseda A, Harris E. Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term. Sci Transl Med. 2021 Oct 06; 13(614):eabg9478.
-
Rouers A, Chng MHY, Lee B, Rajapakse MP, Kaur K, Toh YX, Sathiakumar D, Loy T, Thein TL, Lim VWX, Singhal A, Yeo TW, Leo YS, Vora KA, Casimiro D, Lim B, Tucker-Kellogg L, Rivino L, Newell EW, Fink K. Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection. Cell Rep Med. 2021 05 18; 2(5):100278.
-
Greenbaum U, Klein K, Martinez F, Song J, Thall PF, Ramdial JL, Knape C, Aung FM, Scroggins J, Knopfelmacher A, Mulanovich V, Borjan J, Adachi J, Muthu M, Leung C, Medina MC, Champlin R, Olson A, Alousi A, Rezvani K, Shpall EJ. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients. Front Immunol. 2021; 12:675679.
-
James J, Rhodes S, Ross CS, Skinner P, Smith SP, Shipley R, Warren CJ, Goharriz H, McElhinney LM, Temperton N, Wright E, Fooks AR, Clark TW, Brookes SM, Brown IH, Banyard AC. Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies. Viruses. 2021 04 20; 13(4).
-
Karnaneedi S, Huerlimann R, Johnston EB, Nugraha R, Ruethers T, Taki AC, Kamath SD, Wade NM, Jerry DR, Lopata AL. Novel Allergen Discovery through Comprehensive De Novo Transcriptomic Analyses of Five Shrimp Species. Int J Mol Sci. 2020 Dec 22; 22(1).
-
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021 01 21; 184(2):476-488.e11.